In order to lay a molecular basis for further research on the occurrence and treatment of this disease, RNA-Seq was conducted to explore the differences between APL with FIP1L1::RARA and other hematologic malignancies from the level of transcriptome. Here, FIP1L1 is linked to acute promyelocytic leukemia.